By The Numbers

An exciting year of expansion – in FY22, OTC grew in size and scope, reaching farther upstream in the innovation pipeline and helping shepherd startups farther downstream.

View our 2022 Annual Report

Duke Start-ups: Impact in North Carolina and Beyond In the Past Five Years

By the Numbers
76
Companies formed
$1.8B
Raised in private and public financing
7
IPOs
9
Acquisitions

Annual Reports

Duke is an innovative place to be – we’re bringing cutting edge research out of the lab and into the world.

See our 2022 Annual Report

See our 2021 Annual Report

See our 2020 Annual Report

See our 2019 Annual Report

See our 2018 Annual Report

2022 Impact

316

Disclosures

107

Agreements

116

Issued Patents

$95.7M

In Revenue

Duke Startups

Duke Total Invention Disclosures & Agreements

Spotlight Stories from FY22

Brain Tumor 'Pied Piper' Device Gains Breakthrough Status,
Exvade Biosciences

“This was the first demonstration that you can engineer migration inside the body and move a tumor from point A to point B by design,”…

Read More
View All